When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
NBRV - FDA rejects Nabriva's Contepo application; shares down 28% premarket
Nabriva Therapeutics plc
Nabriva Therapeutics (NASDAQ:NBRV) has received a Complete Response Letter (CRL) from the FDA regarding its marketing application seeking approval for CONTEPO (fosfomycin) for the treatment of complicated urinary tract infections, including acute pyelonephritis.
More news on: Nabriva Therapeutics plc, Healthcare stocks news, Stocks on the move,